Young adult cancer risk behaviours originate in adolescence: a longitudinal analysis using ALSPAC, a UK birth cohort study.

ALSPAC Adolescence Cancer risk behaviours Early adulthood Longitudinal latent class analysis UK birth cohort study

Journal

BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800

Informations de publication

Date de publication:
07 Apr 2021
Historique:
received: 11 11 2020
accepted: 24 03 2021
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 18 5 2021
Statut: epublish

Résumé

An estimated 40% of cancer cases in the UK in 2015 were attributable to cancer risk behaviours. Tobacco smoking, alcohol consumption, obesity, and unprotected sexual intercourse are known causes of cancer and there is strong evidence that physical inactivity is associated with cancer. These cancer risk behaviours co-occur however little is known about how they pattern longitudinally across adolescence and early adulthood. Using data from ALSPAC, a prospective population-based UK birth cohort study, we explored patterns of adolescent cancer risk behaviours and their associations with cancer risk behaviours in early adulthood. Six thousand three hundred fifty-one people (46.0% of ALSPAC participants) provided data on all cancer risk behaviours at one time during adolescence, 1951 provided data on all cancer risk behaviours at all time points. Our exposure measure was quartiles of a continuous score summarising cumulative exposure to cancer risk behaviours and longitudinal latent classes summarising distinct categories of adolescents exhibiting similar patterns of behaviours, between age 11 and 18 years. Using both exposure measures, odds of harmful drinking (Alcohol Use Disorders Identification Test-C ≥ 8),daily tobacco smoking, nicotine dependence (Fagerström test ≥4), obesity (BMI ≥30), high waist circumference (females: ≥80 cm and males: ≥94 cm, and high waist-hip ratio (females: ≥0.85 and males: ≥1.00) at age 24 were estimated using logistic regression analysis. We found distinct groups of adolescents characterised by consistently high and consistently low engagement in cancer risk behaviours. After adjustment, adolescents in the top quartile had greater odds of all outcomes in early adulthood: nicotine dependency (odds ratio, OR = 5.37, 95% confidence interval, CI = 3.64-7.93); daily smoking (OR = 5.10, 95% CI =3.19-8.17); obesity (OR = 4.84, 95% CI = 3.33-7.03); high waist circumference (OR = 2.48, 95% CI = 1.94-3.16); harmful drinking (OR = 2.04, 95% CI = 1.57-2.65); and high waist-hip ratio (OR = 1.88, 95% CI = 1.30-2.71), compared to the bottom quartile. In latent class analysis, adolescents characterised by consistently high-risk behaviours throughout adolescence were at higher risk of all cancer risk behaviours at age 24, except harmful drinking. Exposure to adolescent cancer risk behaviours greatly increased the odds of cancer risk behaviours in early adulthood. Interventions to reduce these behaviours should target multiple rather than single risk behaviours and should focus on adolescence.

Sections du résumé

BACKGROUND BACKGROUND
An estimated 40% of cancer cases in the UK in 2015 were attributable to cancer risk behaviours. Tobacco smoking, alcohol consumption, obesity, and unprotected sexual intercourse are known causes of cancer and there is strong evidence that physical inactivity is associated with cancer. These cancer risk behaviours co-occur however little is known about how they pattern longitudinally across adolescence and early adulthood. Using data from ALSPAC, a prospective population-based UK birth cohort study, we explored patterns of adolescent cancer risk behaviours and their associations with cancer risk behaviours in early adulthood.
METHODS METHODS
Six thousand three hundred fifty-one people (46.0% of ALSPAC participants) provided data on all cancer risk behaviours at one time during adolescence, 1951 provided data on all cancer risk behaviours at all time points. Our exposure measure was quartiles of a continuous score summarising cumulative exposure to cancer risk behaviours and longitudinal latent classes summarising distinct categories of adolescents exhibiting similar patterns of behaviours, between age 11 and 18 years. Using both exposure measures, odds of harmful drinking (Alcohol Use Disorders Identification Test-C ≥ 8),daily tobacco smoking, nicotine dependence (Fagerström test ≥4), obesity (BMI ≥30), high waist circumference (females: ≥80 cm and males: ≥94 cm, and high waist-hip ratio (females: ≥0.85 and males: ≥1.00) at age 24 were estimated using logistic regression analysis.
RESULTS RESULTS
We found distinct groups of adolescents characterised by consistently high and consistently low engagement in cancer risk behaviours. After adjustment, adolescents in the top quartile had greater odds of all outcomes in early adulthood: nicotine dependency (odds ratio, OR = 5.37, 95% confidence interval, CI = 3.64-7.93); daily smoking (OR = 5.10, 95% CI =3.19-8.17); obesity (OR = 4.84, 95% CI = 3.33-7.03); high waist circumference (OR = 2.48, 95% CI = 1.94-3.16); harmful drinking (OR = 2.04, 95% CI = 1.57-2.65); and high waist-hip ratio (OR = 1.88, 95% CI = 1.30-2.71), compared to the bottom quartile. In latent class analysis, adolescents characterised by consistently high-risk behaviours throughout adolescence were at higher risk of all cancer risk behaviours at age 24, except harmful drinking.
CONCLUSIONS CONCLUSIONS
Exposure to adolescent cancer risk behaviours greatly increased the odds of cancer risk behaviours in early adulthood. Interventions to reduce these behaviours should target multiple rather than single risk behaviours and should focus on adolescence.

Identifiants

pubmed: 33827470
doi: 10.1186/s12885-021-08098-8
pii: 10.1186/s12885-021-08098-8
pmc: PMC8028717
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

365

Subventions

Organisme : Cancer Research UK
ID : C60153/A23895
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022206/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29019
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18281/A19169
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Références

Br J Cancer. 2011 Dec 6;105 Suppl 2:S14-8
pubmed: 22158312
J Paediatr Child Health. 2013 Nov;49(11):935-41
pubmed: 24251659
Wellcome Open Res. 2018 Aug 30;3:106
pubmed: 30569020
Br J Cancer. 2011 Dec 6;105 Suppl 2:S38-41
pubmed: 22158319
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Br J Cancer. 2018 Apr;118(8):1130-1141
pubmed: 29567982
J Adolesc Health. 1991 Dec;12(8):597-605
pubmed: 1799569
Pediatrics. 2011 Apr;127(4):e948-55
pubmed: 21402626
Int J Epidemiol. 2019 Aug 1;48(4):1294-1304
pubmed: 30879056
Int J Cancer. 2016 Mar 15;138(6):1380-7
pubmed: 26455822
BMC Pediatr. 2019 Mar 11;19(1):75
pubmed: 30857546
Eur J Public Health. 2015 Feb;25(1):44-9
pubmed: 24963150
Eur J Intern Med. 2016 Oct;34:89-93
pubmed: 27545645
Prev Med. 2020 Sep;138:106157
pubmed: 32473267
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Nat Commun. 2020 Jan 30;11(1):597
pubmed: 32001714
Comput Stat Data Anal. 2010 Oct 1;54(10):2267-2275
pubmed: 24748700
J Stud Alcohol Drugs. 2009 Nov;70(6):859-69
pubmed: 19895762
Cochrane Database Syst Rev. 2014 Apr 16;(4):CD008958
pubmed: 24737131
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
BMC Public Health. 2020 Mar 4;20(1):290
pubmed: 32131789
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
BMJ Open. 2018 Jul 30;8(7):e020182
pubmed: 30061432
Lancet. 2020 Mar 7;395(10226):785-794
pubmed: 31492501
BMJ Open. 2019 Jan 20;9(1):e024858
pubmed: 30662005
Prev Med. 2012 Jun;54(6):393-6
pubmed: 22484392
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Prev Med. 2019 May;122:49-64
pubmed: 31078173
Child Dev. 2003 Nov-Dec;74(6):1581-93
pubmed: 14669883
Br J Cancer. 2011 Dec 6;105 Suppl 2:S34-7
pubmed: 22158318
Nicotine Tob Res. 2008 Aug;10(8):1283-91
pubmed: 18686175
Int J Epidemiol. 2020 Apr 1;49(2):587-596
pubmed: 31802111
BMC Med. 2020 Dec 17;18(1):396
pubmed: 33327948
Br J Cancer. 2011 Dec 6;105 Suppl 2:S6-S13
pubmed: 22158323
Cochrane Database Syst Rev. 2018 Oct 05;10:CD009927
pubmed: 30288738
BMC Med. 2015 Mar 06;13:47
pubmed: 25858476
Health Psychol. 2008 Nov;27(6):811-8
pubmed: 19025277
BMC Public Health. 2014 Nov 25;14:1215
pubmed: 25420729

Auteurs

Caroline Wright (C)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK. caroline.wright@bristol.ac.uk.

Jon Heron (J)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK.
MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ruth Kipping (R)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK.

Matthew Hickman (M)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK.

Rona Campbell (R)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK.

Richard M Martin (RM)

Department of Population Health Sciences, Population Health Sciences, Bristol Medical School, University of Bristol, BF4, Barley House, Oakfield Grove, Bristol, BS8 2BN, UK.
MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH